Thorne HealthTech Acquires Majority of Drawbridge Health

May 25, 2021

Thorne HealthTech acquired a majority of outstanding shares of Drawbridge Health, the developer of the OneDraw blood collection device and A1C Test System. Drawbridge Health will remain a majority‑owned and controlled subsidiary, with its former CEO Lee McCraken staying on as chairman while new co‑CEOs lead growth and integration efforts.

Buyers
Thorne HealthTech
Targets
Drawbridge Health
Industry
Medical Devices
Location
New York, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.